Concepedia

Ruixuan Jiang

RJ

16

Publications

1.1K

Citations

13

H-Index

2004

Active since

Affiliations

University of Illinois Chicago(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Universitätsmedizin Greifswald

Erasmus University Rotterdam

University of Tübingen

Ruixuan Jiang is an author at University of Illinois Chicago specializing in medicine, outcomes research, and oncology.

Top concepts

MedicineOncologyCancer TherapyCancer ResearchOutcomes ResearchPharmacotherapyPharmacogeneticsPharmacogenomicsRadiation OncologyPatient-reported Outcomes

Publications per year

2004–2024

16

Publications

16

United States Valuation of EQ-5D-5L Health States Using an International Protocol

A. Simon Pickard, Ernest H. Law, Ruixuan Jiang et al. · Value in Health · 2019 · 360 citations · Full text

US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples

Ruixuan Jiang, Mathieu F. Janssen, A. Simon Pickard · Quality of Life Research · 2020 · 205 citations · Full text

Selenium and Colorectal Adenoma: Results of a Pooled Analysis

Elizabeth T. Jacobs, Ruixuan Jiang, David S. Alberts et al. · JNCI Journal of the National Cancer Institute · 2004 · 157 citations · Full text

The societal cost of heroin use disorder in the United States

Ruixuan Jiang, In-Young Lee, Todd A. Lee et al. · PLoS ONE · 2017 · 65 citations · Full text

Using Patient-reported Outcomes to Compare Relative Burden of Cancer: EQ-5D and Functional Assessment of Cancer Therapy-General in Eleven Types of Cancer

A. Simon Pickard, Ruixuan Jiang, Hsiang-Wen Lin et al. · Clinical Therapeutics · 2016 · 44 citations · Full text

Functional Assessment, Patient-reported Outcomes, Medicine +7

Rows per page

1–5 of 16